Archives
[Preprint] High prevalence of olfactory disorders 18 months after contracting COVID-19.
26 Jan, 2022 | 02:11h | UTCHigh prevalence of olfactory disorders 18 months after contracting COVID-19 – medRxiv
Commentaries:
Half of first-wave Covid cases may have lasting harm to sense of smell – The Guardian
Prevalence of olfactory dysfunction 18 months after SARS-CoV-2 infection – News Medical
RCT: Acetazolamide prevents adverse altitude effects in COPD and healthy adults.
26 Jan, 2022 | 01:53h | UTCAcetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults – NEJM Evidence
Mass casualty medicine and anesthesia special issue: science and clinical practice.
26 Jan, 2022 | 02:04h | UTCEditorials:
Mass casualty medicine: time for a 21st century refresh
Exercising for mass casualty preparedness
Massive transfusion and severe blood shortages: establishing and implementing predictors of futility
Transfusion support during mass casualty events
Embracing uncertainty in mass casualty incidents
Pre-hospital critical care at major incidents
Provision of pre-hospital medical care for terrorist attacks
Global lessons learned from COVID-19 mass casualty incidents
Reimagining health preparedness in the aftermath of COVID-19
Preparing for mass casualty events despite COVID-19
Paediatric Anaesthesia:
Paediatric patients in mass casualty incidents: a comprehensive review and call to action
Pre-hospital Care:
Injury scoring systems for blast injuries: a narrative review
Preparedness:
Learning from terrorist mass casualty incidents: a global survey
Refining mass casualty plans with simulation-based iterative learning
Specific Incidents:
Mass casualty, intentional vehicular trauma and anaesthesia
Correspondence:
Development and evaluation of a mass casualty medicine simulation method using figurines
RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment.
26 Jan, 2022 | 01:58h | UTC
Commentary on Twitter
In this 2-year study, data showed that electronic directly observed therapy (eDOT) was as effective as traditional in-person DOT for ensuring high adherence to treatment of tuberculosis disease. @CDC_TB @nycHealthy @ColumbiaMed https://t.co/yTrU1JRuwn pic.twitter.com/QXthE4d266
— JAMA Network Open (@JAMANetworkOpen) January 20, 2022
Perspective: The value of patient-reported outcomes in early-phase clinical trials.
26 Jan, 2022 | 01:47h | UTCThe value of patient-reported outcomes in early-phase clinical trials – Nature Medicine (if the link is paywalled, try this one)
Commentary on Twitter
A @NatureMedicine Comment article argues that patient-reported outcomes, if used correctly, can provide preliminary evidence of efficacy and tolerability from a patient perspective, as well as supporting regulatory review. https://t.co/4ztwW76P2T pic.twitter.com/6sFRvswgJ2
— Nature Portfolio (@NaturePortfolio) January 24, 2022
A review of high impact journals found that misinterpretation of non-statistically significant results from randomized trials was common.
26 Jan, 2022 | 01:50h | UTC
Opinion | “The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice”.
26 Jan, 2022 | 01:52h | UTCCommentary: ‘Unproven and unethical’: experts warn against genetic embryo tests – The Guardian
A registry study with 1,581 cases of Stenotrophomonas maltophilia blood and/or lower respiratory infections suggest Levofloxacin is a reasonable alternative to standard therapy with Trimethoprim-sulfamethoxazole.
26 Jan, 2022 | 01:40h | UTC
Commentary on Twitter
A new study in OFID suggests that mortality outcomes are similar comparing levofloxacin and TMP/SMX treatment of S. maltophilia lower respiratory tract and bloodstream infections.
📄:https://t.co/80QDy3DTU9 #IDSAJournals @PaulSaxMD @DrJLi @Keith_S_Kaye @SameerKadri12 pic.twitter.com/TNxQpfT97n
— IDSA (@IDSAInfo) January 23, 2022
An artificial intelligence system can help predict myocardial infarction through retinal scans and minimal personal information.
26 Jan, 2022 | 01:44h | UTCNews release: Using the eye as a window into heart disease – University of Leeds
Original study: Predicting myocardial infarction through retinal scans and minimal personal information – Nature Machine Intelligence (link to abstract – $ for full-text)
Fever of unknown origin and incidence of cancer: a population-based cohort study using nationwide Danish registries showed that cancer risk in one year was 1.2%.
26 Jan, 2022 | 01:36h | UTCFever of unknown origin and incidence of cancer – Clinical Infectious Diseases (link to abstract – $ for full-text)
Systematic Review: Ultrafiltration for acute heart failure.
26 Jan, 2022 | 01:33h | UTCUltrafiltration for acute heart failure – Cochrane Library
Commentary: Fluid removal therapy in acute heart failure – Cochrane Library
Systematic Review: Delayed introduction of progressive enteral feeds to prevent necrotizing enterocolitis in very low birth weight infants.
26 Jan, 2022 | 01:27h | UTC
Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold.
26 Jan, 2022 | 01:31h | UTCOral antihistamine‐decongestant‐analgesic combinations for the common cold – Cochrane Library
Commentary: Oral antihistamine-decongestant-analgesic combinations for the common cold – Cochrane Library
Review: Point-of-care ultrasound for the trauma anesthesiologist.
26 Jan, 2022 | 01:22h | UTCPoint-of-Care Ultrasound for the Trauma Anesthesiologist – Current Anesthesiology Reports (if the link is paywalled, try this one)
Systematic Review: Short intravenous antibiotic courses for urinary infections in young infants.
26 Jan, 2022 | 01:24h | UTCShort Intravenous Antibiotic Courses for Urinary Infections in Young Infants: A Systematic Review – Pediatrics (link to abstract – $ for full-text)
Supplement: Irritable bowel syndrome and related conditions.
26 Jan, 2022 | 01:21h | UTCHomepage: IBS and Related Conditions – Alimentary Pharmacology and Therapeutics
Review article: epidemiology of IBS and other bowel disorders of gut–brain interaction (DGBI)
Review article: Physical and psychological comorbidities associated with irritable bowel syndrome
Review article: Diagnosis and investigation of irritable bowel syndrome
Review article: current and future treatment approaches for IBS with constipation
Review article: current and future treatment approaches for pain in IBS
Review: Genotypic and phenotypic characteristics of hereditary colorectal cancer.
26 Jan, 2022 | 01:16h | UTCGenotypic and Phenotypic Characteristics of Hereditary Colorectal Cancer – Annals of Coloproctology
ASCO-SNO Guideline: Therapy for diffuse astrocytic and oligodendroglial tumors in adults.
26 Jan, 2022 | 01:19h | UTC
RCT: CPAP improved outcomes in patients with acute hypoxemic respiratory failure due to COVID-19, but high-flow nasal oxygen was not better than conventional oxygen therapy.
25 Jan, 2022 | 09:50h | UTCEditorial: Defining Optimal Respiratory Support for Patients With COVID-19 – JAMA
Commentary on Twitter
RCT of patients with acute hypoxemic respiratory failure due to #COVID19 found an initial strategy of CPAP, compared with conventional oxygen therapy, significantly reduced the composite outcome of tracheal intubation or mortality within 30 days. https://t.co/fznFigiFmu pic.twitter.com/b7mHssbfkp
— JAMA (@JAMA_current) January 24, 2022
Review: Treatment for peritoneal metastasis of patients with colorectal cancer.
26 Jan, 2022 | 01:17h | UTCTreatment for Peritoneal Metastasis of Patients With Colorectal Cancer – Annals of Coloproctology
ACP living, rapid review: risk for reinfection after SARS-CoV-2.
25 Jan, 2022 | 09:47h | UTC
Commentary on Twitter
Risk for Reinfection After #SARSCoV2: previous infection reduced risk for reinfection by 87% (95% CI, 84% to 90%). Protection remained above 80% for at least 7 months, but no study followed patients after the emergence of the Delta or #Omicron variant. https://t.co/eruEf1w8Vo
— Prof. Nick Talley (@Prof_NickTalley) January 25, 2022
New CPR guidance addresses more contagious COVID-19 variants amidst evolving pandemic.
25 Jan, 2022 | 09:48h | UTCNews release: New CPR guidance addresses more contagious COVID-19 variants amidst evolving pandemic – American Heart Association
WHO drops opposition to boosters – recommends third Pfizer jab for adults & two vaccines for children ages 5 & up.
25 Jan, 2022 | 09:45h | UTCRelated:
WHO updated roadmap for prioritizing uses of COVID-19 vaccines.
WHO advisers weigh in on COVID-19 boosters, Pfizer vaccine in younger kids.
A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.
25 Jan, 2022 | 09:43h | UTCNews release: BNT162b2 COVID-19 vaccine associated with increased risk of carditis – American College of Physicians
Related:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa.
25 Jan, 2022 | 09:41h | UTCCommentary: Omicron severity: milder but not mild – The Lancet
Commentary on Twitter
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in S. Africa, Lancet. Individuals with Omicron vs previous infections 80% lower odds of being admitted to hospital, 70% lower odds of severe disease than Deltahttps://t.co/528NWfKrDN
— Monica Gandhi MD, MPH (@MonicaGandhi9) January 23, 2022